Christiane Fuerst

Title: Christiane Fuerst: Innovator in Insulin Formulations

Introduction

Christiane Fuerst is a notable inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. Her work has had a profound impact on diabetes treatment, showcasing her dedication to improving patient care.

Latest Patents

Christiane Fuerst holds a patent for "Long-acting formulations of insulin." This patent relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL of insulin glargine, which is equimolar to 200-1000 IU of human insulin. This innovation represents a crucial advancement in the management of diabetes, providing patients with more effective treatment options.

Career Highlights

Throughout her career, Christiane has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis Deutschland GmbH. Her experience in these organizations has allowed her to develop and refine her expertise in pharmaceutical formulations, particularly in insulin delivery systems.

Collaborations

Christiane has collaborated with esteemed colleagues such as Reinhard Becker and Annke Hahn. These partnerships have contributed to her success and the advancement of her innovative work in the field of insulin formulations.

Conclusion

Christiane Fuerst is a pioneering inventor whose work in insulin formulations has significantly impacted diabetes treatment. Her dedication to innovation and collaboration continues to inspire advancements in the pharmaceutical industry.